PAM
SLXP

Panagora Asset Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Panagora Asset Management’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-48,531
Closed -$8.39M – 2551
2015
Q1 		$8.39M Buy
48,531
+16,920
+54% +$2.48M 0.04% 374
2014
Q4 		$3.63M Buy
31,611
+9,305
+42% +$1.13M 0.02% 556
2014
Q3 		$3.48M Sell
22,306
-47,360
-68% -$6.87M 0.02% 590
2014
Q2 		$8.59M Sell
69,666
-33,200
-32% -$3.67M 0.04% 388
2014
Q1 		$10.7M Buy
102,866
+59,358
+136% +$6.08M 0.05% 343
2013
Q4 		$3.91M Buy
43,508
+29,380
+208% +$2.34M 0.02% 609
2013
Q3 		$945K Hold
14,128
– – ﹤0.01% 1130
2013
Q2 		$935K Buy
+14,128
New +$808K ﹤0.01% 1084

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Panagora Asset Management's SLXP Position: Q2 2015 in Review

Panagora Asset Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 48,531 shares — an estimated $8.39M sold.

Panagora Asset Management first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $10.7M in Q1 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Panagora Asset Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Panagora Asset Management sold 48,531 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $8.39M.
  • Panagora Asset Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • Panagora Asset Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $10.7M in Q1 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Panagora Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.